Skip to main content
TipRanks
Go Ultimate75% OFF

Alnylam Pharma (ALNY) Q1 2026 Earnings Report

0 Followers

MX:ALNY Q1 2026 EPS Results

Actual EPS
MXN 28.57
Consensus EPS
MXN 16.50
Beat/Miss
Beat by +MXN 12.07
One Year Ago EPS
-MXN 8.33

MX:ALNY Q1 2026 Revenue Results

Actual Revenue
MXN 22.09B
Expected Revenue
MXN 21.11B
Beat/Miss
Beat by +MXN 977.61M
YoY Revenue Growth
+96.43%

Earnings Announcement Details

Quarter
Q1 2026
Date
04/30/2026
Time
Before Open
Conference Call
Thursday, April 30, 2026
MX:ALNY Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q1 2026 Earnings Call Audio

MX:ALNY Q1 2026 Earnings Call
0:00 / 0:00

Q1 2026 Earnings Slide Deck

Q1 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:ALNY Earnings History

MX:ALNY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)32.60-15.52――
Oct 29, 20262026 (Q3)31.41297.4734.82754.35% (+262.65)
Jul 30, 20262026 (Q2)30.8422.90-9.65337.25% (+32.55)
Apr 30, 20262026 (Q1)16.5028.57-8.33443.18% (+36.90)
Feb 12, 20262025 (Q4)21.7615.52-12.3226.15% (+27.82)
Oct 30, 20252025 (Q3)10.6234.82-16.46311.49% (+51.28)
Jul 31, 20252025 (Q2)-10.29-9.65-2.46-292.31% (-7.19)
May 01, 20252025 (Q1)-16.84-8.33-9.8415.38% (+1.51)
Feb 13, 20252024 (Q4)-11.20-12.30-20.8240.91% (+8.52)
Oct 31, 20242024 (Q3)-17.35-16.4621.76-175.65% (-38.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed